Lisa F. Newcomb

Also affiliated with Fred Hutch Cancer Center

MedicineEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Time-dependent predictive accuracy metrics in the context of interval censoring and competing risks

Zenodo (CERN European Organization for Nuclear Research)(2025)10.5281/zenodo.17841742

Top 100%

0DataRank

Top 100%0 citations

Dimitris Rizopoulos, Lisa F. Newcomb, Nicole S. Erler, Zhenwei Yang

Papers

Driven by 18 papers — median percentile 0. Top paper: “Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis”.

Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis

Diabetologia(2023)10.1007/s00125-023-05925-4

N/A

0.553DataRank · unranked

39 citations

Emmanouil Bouras, Andrei‐Emil Constantinescu, Kimberley Burrows, Caroline J. Bull, Emma E. Vincent +92 more

Proposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group and pathological stage

Histopathology(2024)10.1111/his.15231

N/A

0.524DataRank · unranked

32 citations

Lara R. Harik, Eric A. Klein, Jianbo Li, Dillon Corrigan, Shiguang Liu +18 more

Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry

The American Journal of Human Genetics(2023)10.1016/j.ajhg.2023.05.010

N/A

0.494DataRank · unranked

26 citations

Jiayi Shen, Ravi Madduri, Alexis Rodriguez, Yukai Xiao, Xin Sheng +95 more

Genetic factors associated with prostate cancer conversion from active surveillance to treatment

Human Genetics and Genomics Advances(2021)10.1016/j.xhgg.2021.100070

N/A

0.477DataRank · unranked

23 citations

Travis J. Meyers, Adaeze A. Emeka, Lauren Folgosa Cooley, Phillip R. Cooper, Nicola Lancki +92 more

Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment

medRxiv(2021)10.1101/2021.08.30.21262305

N/A

0.406DataRank · unranked

14 citations

Travis J. Meyers, Adaeze A. Emeka, Lauren Folgosa Cooley, Phillip R. Cooper, Nicola Lancki +92 more

Observational and genetic associations between cardiorespiratory fitness and cancer: a UK Biobank and international consortia study

British Journal of Cancer(2023)10.1038/s41416-023-02489-3

N/A

0.330DataRank · unranked

8 citations

Tomas I. Gonzales, Tessa Strain, Pedro F. Saint‐Maurice, D. Timothy Bishop, Stephen J. Chanock +89 more

Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective Study

Modern Pathology(2023)10.1016/j.modpat.2023.100241

N/A

0.330DataRank · unranked

8 citations

Stephanie A. Harmon, Rachael Iseman, Olga Ludkowski, Heidi Auman, Sarah T. Hawley +28 more

Evaluating Approaches for Constructing Polygenic Risk Scores for Prostate Cancer in Men of African and European Ancestry

medRxiv(2023)10.1101/2023.05.12.23289860

N/A

0.165DataRank · unranked

2 citations

Jiayi Shen, Ravi Madduri, Alexis Rodriguez, Yukai Xiao, Xin Sheng +95 more

Constructing Time-Invariant Dynamic Surveillance Rules for Optimal Monitoring Schedules

Biometrics(2023)10.1111/biom.13911

N/A

0.165DataRank · unranked

2 citations

Yingye Zheng, Daniel W. Lin, Lisa F. Newcomb, Ying‐Qi Zhao, Xinyuan Dong

Germline mutations in penetrant cancer predisposition genes are rare in men with prostate cancer selecting active surveillance

Cancer Medicine(2022)10.1002/cam4.4778

N/A

0DataRank · unranked

10 citations

Lisa F. Newcomb, Kehao Zhu, Yingye Zheng, Hilary Boyer, Navonil De Sarkar +16 more

Germline variation at 8q24 and prostate cancer risk in men of European ancestry

UNC Libraries(2023)10.17615/ejg2-ya10

N/A

0DataRank · unranked

0 citations

Victoria L. Stevens, Kan Wang, Nawaid Usmani, Radka Kaneva, C.A. Haiman +73 more

Treatment in the absence of disease reclassification among men on active surveillance for prostate cancer

Cancer(2021)10.1002/cncr.33911

N/A

0DataRank · unranked

8 citations

Kehao Zhu, Yingye Zheng, Lisa F. Newcomb, Jeannette M. Schenk, James D. Brooks +15 more

High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarker

Scientific Reports(2024)10.1038/s41598-023-50215-z

N/A

0DataRank · unranked

11 citations

Sarah Hawley, Christian A. Kunder, En‐Chi Hsu, Michelle Shen, Lennart Westphalen +17 more

A Bayesian Joint Modelling for Misclassified Interval-censoring and Competing Risks

arXiv (Cornell University)(2024)10.48550/arxiv.2404.09362

N/A

0DataRank · unranked

0 citations

Dimitris Rizopoulos, Eveline A.M. Heijnsdijk, Lisa F. Newcomb, Nicole S. Erler, Yang, Zhenwei

Personalized Biopsy Schedules Using an Interval‐Censored Cause‐Specific Joint Model

Statistics in Medicine(2025)10.1002/sim.70134

N/A

0DataRank · unranked

2 citations

Dimitris Rizopoulos, Eveline A.M. Heijnsdijk, Lisa F. Newcomb, Nicole S. Erler, Zhenwei Yang

Improving Efficiency and Robustness of the Prognostic Accuracy of Biomarkers With Partial Incomplete Failure‐Time Data and Auxiliary Outcome: Application to Prostate Cancer Active Surveillance Study

Statistics in Medicine(2025)10.1002/sim.70072

N/A

0DataRank · unranked

0 citations

Tianxi Cai, Lisa F. Newcomb, Daniel Lin, Yingye Zheng, Yunro Chung

Time-dependent predictive accuracy metrics in the context of interval censoring and competing risks

Zenodo (CERN European Organization for Nuclear Research)(2025)10.5281/zenodo.17841742

Top 100%

0DataRank

Top 100%0 citations

Dimitris Rizopoulos, Lisa F. Newcomb, Nicole S. Erler, Zhenwei Yang

Time-dependent predictive accuracy metrics in the context of interval censoring and competing risks

Zenodo (CERN European Organization for Nuclear Research)(2025)10.5281/zenodo.17841743

Top 100%

0DataRank

Top 100%0 citations

Dimitris Rizopoulos, Lisa F. Newcomb, Nicole S. Erler, Zhenwei Yang

Lisa F. Newcomb

Indexed papers

Top data-sharing exemplar

Papers